UPDATE: UBS Starts HEALTHSOUTH (HLS) at Buy; Compelling Demographic Trends

July 3, 2012 6:55 AM EDT Send to a Friend
Get Alerts HLS Hot Sheet
Price: $38.25 -0.65%

Rating Summary:
    8 Buy, 5 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 13 | Down: 18 | New: 41
Trade HLS Now!
Join SI Premium – FREE
(Updated - July 3, 2012 12:47 PM EDT)

UBS initiates coverage on HEALTHSOUTH (NYSE: HLS) with a Buy. PT $30.00.

Analyst, A.J. Rice, said, "HLS should continue to benefit from the aging of America and the desire of seniors to maintain an active lifestyle...Given strong operating trends, we would not be surprised to see positive estimate revisions at HLS as the year progresses. The company did not raise its 2012 guidance despite reporting strong 1Q12 results. Resolution of the company’s long-standing arbitration with its former auditors, Ernst & Young, could be a further positive catalyst for the HLS shares and also drive a positive estimate revision."

For an analyst ratings summary and ratings history on HEALTHSOUTH click here. For more ratings news on HEALTHSOUTH click here.

Shares of HEALTHSOUTH closed at $23.35 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

New Coverage

Related Entities

UBS

Add Your Comment